Perhavec Andraz, Besić Nikola, Hocevar Marko, Zgajnar Janez
Department of Surgical Oncology, Institute of Oncology Ljubljana, Zaloska Cesta 2, 1000 Ljubljana, Slovenia.
Ann Surg Oncol. 2008 Aug;15(8):2257-62. doi: 10.1245/s10434-008-9957-3. Epub 2008 May 17.
Touch imprint cytology (TIC) is a fast, cheap and specific intraoperative examination of the sentinel lymph nodes (SLNs) in early breast cancer patients. The results of TIC in patients with ultrasonically (US) uninvolved axillary lymph nodes are not known. The objective of our study was to compare the results of TIC in the patients with US uninvolved axillary lymph nodes (US group) and those with only clinically uninvolved axillary lymph nodes (non-US group).
A total of 470 patients were included in the study, 257 in the US group and 213 in the non-US group. TIC results were compared to the definite histology, and the sensitivity of TIC was calculated for both groups of patients. A subgroup analysis of TIC findings with regard to the primary tumor size was performed.
Overall sensitivity and sensitivity for detecting macrometastases was significantly lower in the US group compared with the non-US group. In the US group, TIC results changed the course of treatment in 9% of patients, while in the non-US group, the course of treatment was changed in 22% of patients. In the non-US group, the proportion of positive TIC results increased with increasing tumor size, whereas in the US group it did not.
The sensitivity of TIC is lower in the patients with US uninvolved axillary lymph nodes compared to those with only clinically uninvolved axillary lymph nodes. TIC might not be indicated in patients with US uninvolved axillary lymph nodes as it changes the course of treatment in only 9% of patients.
触摸印片细胞学检查(TIC)是一种快速、廉价且特异的针对早期乳腺癌患者前哨淋巴结(SLN)的术中检查方法。超声(US)检查腋窝淋巴结未受累患者的TIC结果尚不清楚。我们研究的目的是比较超声检查腋窝淋巴结未受累患者(US组)和仅临床检查腋窝淋巴结未受累患者(非US组)的TIC结果。
本研究共纳入470例患者,其中US组257例,非US组213例。将TIC结果与确切的组织学结果进行比较,并计算两组患者TIC的敏感性。对TIC结果按原发肿瘤大小进行亚组分析。
与非US组相比,US组的总体敏感性及检测大转移灶的敏感性显著更低。在US组,TIC结果改变了9%患者的治疗方案,而在非US组,22%患者的治疗方案被改变。在非US组,TIC阳性结果的比例随肿瘤大小增加而升高,而在US组则不然。
与仅临床检查腋窝淋巴结未受累的患者相比,超声检查腋窝淋巴结未受累患者的TIC敏感性更低。对于超声检查腋窝淋巴结未受累的患者,TIC可能并不适用,因为它仅能改变9%患者的治疗方案。